Literature DB >> 22566247

Very-low-dose continuous drip infusion of landiolol hydrochloride for postoperative atrial tachyarrhythmia in patients with poor left ventricular function.

Akimasa Morisaki1, Mitsuharu Hosono, Yasuyuki Sasaki, Hidekazu Hirai, Masanori Sakaguchi, Atsushi Nakahira, Hiroyuki Seo, Shigefumi Suehiro.   

Abstract

Three patients with poor left ventricular function (left ventricular ejection fraction <30 %) developed postoperative atrial tachyarrhythmia in intensive care. Case 1 was a 64-year-old man who underwent a modified Bentall procedure and mitral valve annuloplasty. Case 2 was a 63-year-old woman who underwent quintuple coronary artery bypass grafting. Case 3 was a 65-year-old man who underwent mitral valve replacement. Preoperative intra-aortic balloon pumping was required in Cases 2 and 3. Excellent heart rate control with no hemodynamic deterioration was achieved in all three cases by very-low-dose continuous drip infusion of landiolol hydrochloride (2-5 μg/kg/min). Very-low-dose continuous drip infusion of landiolol hydrochloride is a safe and useful alternative for the control of perioperative atrial tachyarrhythmias in patients with poor left ventricular function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22566247     DOI: 10.1007/s11748-012-0011-9

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  13 in total

1.  Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101.

Authors:  S Iguchi; H Iwamura; M Nishizaki; A Hayashi; K Senokuchi; K Kobayashi; K Sakaki; K Hachiya; Y Ichioka; M Kawamura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1992-06       Impact factor: 1.645

2.  Effect of beta-blockade on low-dose dobutamine-induced changes in left ventricular function in healthy volunteers: assessment by gated SPET myocardial perfusion scintigraphy.

Authors:  H Everaert; C Vanhove; P R Franken
Journal:  Eur J Nucl Med       Date:  2000-04

3.  Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.

Authors:  H Atarashi; A Kuruma; M Yashima; H Saitoh; T Ino; Y Endoh; H Hayakawa
Journal:  Clin Pharmacol Ther       Date:  2000-08       Impact factor: 6.875

4.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; José Luis Zamorano
Journal:  J Am Coll Cardiol       Date:  2006-08-15       Impact factor: 24.094

Review 5.  Basic pharmacology of esmolol.

Authors:  R J Gorczynski
Journal:  Am J Cardiol       Date:  1985-10-23       Impact factor: 2.778

Review 6.  Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery.

Authors:  Najmeddine Echahidi; Philippe Pibarot; Gilles O'Hara; Patrick Mathieu
Journal:  J Am Coll Cardiol       Date:  2008-02-26       Impact factor: 24.094

7.  The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease.

Authors:  Koji Goto; Chihiro Shingu; Shinji Miyamoto; Hiroshi Miyakawa; Takayuki Noguchi
Journal:  J Clin Anesth       Date:  2007-11       Impact factor: 9.452

8.  Clinical role and efficacy of landiolol in the intensive care unit.

Authors:  Yuko Yoshida; Katsuyuki Terajima; Chiyo Sato; Shinji Akada; Yasuo Miyagi; Takashi Hongo; Shinhiro Takeda; Keiji Tanaka; Atsuhiro Sakamoto
Journal:  J Anesth       Date:  2008-02-27       Impact factor: 2.078

9.  Effect of beta-adrenergic receptor blockade on the physiologic response to dobutamine stress echocardiography.

Authors:  N J Weissman; M W Levangie; J B Newell; J L Guerrero; A E Weyman; M H Picard
Journal:  Am Heart J       Date:  1995-08       Impact factor: 4.749

10.  Conversion of atrial flutter to sinus rhythm during landiolol infusion.

Authors:  Shunsuke Yamamoto; Koji Goto; Yoshifumi Ohchi; Norihisa Yasuda; Chihiro Shingu; Takayuki Noguchi
Journal:  J Anesth       Date:  2009-12-29       Impact factor: 2.078

View more
  3 in total

1.  Acute rate control in atrial fibrillation: an urgent need for the clinician.

Authors:  Gheorghe-Andrei Dan; Anca R Dan; Andreea Ivanescu; Adrian C Buzea
Journal:  Eur Heart J Suppl       Date:  2022-06-13       Impact factor: 1.624

Review 2.  Novel rate control strategy with landiolol in patients with cardiac dysfunction and atrial fibrillation.

Authors:  Teruhiko Imamura; Koichiro Kinugawa
Journal:  ESC Heart Fail       Date:  2020-07-14

3.  Landiolol for rate control management of atrial fibrillation in patients with cardiac dysfunction.

Authors:  Stephan von Haehling; Jan Bělohlávek; Fikret Er; Natig Gassanov; Fabio Guarracino; Olivier Bouvet
Journal:  Eur Heart J Suppl       Date:  2018-01-08       Impact factor: 1.803

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.